ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DONALD WOOD M.D.

Cardiovascular Disease

6,606

$452K

802
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $84

JOHN VITARELLO M.D.

Cardiovascular Disease

5,664

$460K

672
597 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $84

LUCY VANVOORHEES M.D.

Cardiovascular Disease

5,168

$391K

625
576 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $84

TODD NOREUIL MD

Cardiovascular Disease

7,233

$320K

618
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $84

ANTHONY FREY M.D.

Cardiovascular Disease

6,990

$383K

581
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $84

KUSAY BARAKAT M.D.

Cardiovascular Disease

5,079

$429K

541
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $84

BRIAN KAHN MD

Cardiovascular Disease

3,894

$267K

534
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $84

JEFFREY WIELAND M.D.

Cardiovascular Disease

3,205

$257K

496
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $84

HITESH PATEL MD

Cardiovascular Disease

4,712

$375K

480
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $84

JERALD INSEL M.D.

Cardiovascular Disease

3,867

$341K

478
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $84

DENNIS CHODNICKI M.D.

Cardiovascular Disease

3,420

$252K

461
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $84

DAVID RUBIN MD

Cardiovascular Disease

3,416

$292K

456
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $84

DINESH KALARIA M.D.

Cardiovascular Disease

4,355

$345K

450
421 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $84

THOMAS SINDERSON M.D.

Cardiovascular Disease

1,626

$136K

448
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $84

STEPHEN PLANTHOLT M.D.

Cardiovascular Disease

3,697

$235K

433
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $84

DENNIS FRIEDMAN M.D.

Cardiovascular Disease

3,327

$365K

411
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$110
Average prescription price

Avg: $84

ALI TABRIZCHI D.O.

Cardiovascular Disease

2,147

$262K

394
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$122
Average prescription price

Avg: $84

RONALD SCHECHTER M.D.

Cardiovascular Disease

2,714

$214K

390
368 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $84

ROGER STEVENSON M.D.

Cardiovascular Disease

1,392

$112K

379
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $84

JEFFREY BROWN M.D.

Cardiovascular Disease

2,658

$182K

376
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $84

REED SHNIDER MD

Cardiovascular Disease

3,013

$285K

368
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $84

MARK APPLEFELD MD

Cardiovascular Disease

3,035

$267K

366
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $84

DOU ZHANG MD-PHD

Cardiovascular Disease

1,572

$99.9K

363
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $84

JAMES PORTERFIELD M.D.

Cardiovascular Disease

2,506

$267K

361
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $84

TUNG DAO M.D.

Cardiovascular Disease

1,213

$106K

358
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $84

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank